$RMD
RESMED INC Stock $rmd

$rmd Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000094381922000010 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$950.3M	$914.7M	$3.578B
YoY Change	5.12%	4.41%	11.93%
Cost Of Revenue	$409.5M	$392.2M	$1.554B
YoY Change	2.96%	1.77%	14.44%
Gross Profit	$540.8M	$522.5M	$2.024B
YoY Change	6.82%	6.48%	10.07%
Gross Profit Margin	56.91%	57.12%	56.57%
Selling, General & Admin	$193.9M	$194.9M	$739.4M
YoY Change	9.74%	7.39%	10.29%
% of Gross Profit	35.86%	37.3%	36.52%
Research & Development	$63.19M	$64.32M	$253.6M
YoY Change	5.4%	7.42%	12.56%
% of Gross Profit	11.68%	12.31%	12.53%
Depreciation & Amortization	$36.27M	$37.41M	$159.6M
YoY Change	-7.23%	1.78%	1.82%
% of Gross Profit	6.71%	7.16%	7.88%
Operating Expenses	$265.1M	$267.1M	$1.024B
YoY Change	8.47%	7.25%	9.47%
Operating Profit	$275.7M	$255.4M	$1.000B
YoY Change	5.28%	5.69%	10.69%
Interest Expense	-$12.44M	-$19.78M	-$43.00M
YoY Change	-332.13%	199.82%	-279.25%
% of Operating Profit	-4.51%	-7.74%	-4.3%
Other Income/Expense, Net	-$13.95M	$2.468M	-$39.80M
YoY Change	346.27%	-40.8%	98.86%
Pretax Income	$261.8M	$238.1M	$960.5M
YoY Change	1.16%	-0.47%	8.69%
Income Tax	$51.32M	$43.03M	$181.0M
% Of Pretax Income	19.6%	18.07%	18.85%
Net Earnings	$210.5M	$195.1M	$779.4M
YoY Change	3.37%	-0.02%	64.26%
Net Earnings / Revenue	22.15%	21.32%	21.78%
Basic Earnings Per Share	$1.44		$5.34
Diluted Earnings Per Share	$1.43	$1.326M	$5.30
COMMON SHARES
Basic Shares Outstanding	146.4M shares	146.3M shares	146.1M shares
Diluted Shares Outstanding	147.1M shares		147.0M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$207.2M	$273.7M	$273.7M
YoY Change	-24.98%	-7.3%	-7.3%
Cash & Equivalents	$207.2M	$273.7M	$273.7M
Short-Term Investments
Other Short-Term Assets	$126.1M	$131.3M	$312.2M
YoY Change	-37.59%	1.92%	58.28%
Inventory	$864.9M	$743.9M	$743.9M
Prepaid Expenses
Receivables	$620.5M	$576.0M	$601.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.034B	$1.931B	$1.931B
YoY Change	28.21%	22.65%	22.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$487.4M	$498.2M	$630.5M
YoY Change	4.29%	7.48%	6.49%
Goodwill	$1.939B	$1.936B
YoY Change	0.87%	0.44%
Intangibles
YoY Change
Long-Term Investments	$7.890M	$9.918M	$9.918M
YoY Change	-49.96%	-42.18%	-42.18%
Other Assets	$173.4M	$171.7M	$232.7M
YoY Change	6.4%	6.73%	7.03%
Total Long-Term Assets	$3.144B	$3.164B	$3.164B
YoY Change	0.03%	0.35%	0.35%
TOTAL ASSETS
Total Short-Term Assets	$2.034B	$1.931B	$1.931B
Total Long-Term Assets	$3.144B	$3.164B	$3.164B
Total Assets	$5.178B	$5.096B	$5.096B
YoY Change	9.48%	7.78%	7.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$181.5M	$159.2M	$159.2M
YoY Change	4.48%	15.39%	15.39%
Accrued Expenses	$324.1M	$344.7M	$366.6M
YoY Change	18.22%	7.52%	6.51%
Deferred Revenue	$108.2M	$108.7M
YoY Change	-3.85%	-0.86%
Short-Term Debt	$9.906M	$9.916M	$0.00
YoY Change	-17.45%	-17.37%
Long-Term Debt Due	$9.906M	$9.916M	$9.916M
YoY Change	-17.45%	-17.37%	-17.37%
Total Short-Term Liabilities	$692.7M	$689.3M	$689.3M
YoY Change	10.97%	-24.4%	-24.4%
LONG-TERM LIABILITIES
Long-Term Debt	$785.4M	$765.3M	$765.3M
YoY Change	-1.04%	18.96%	18.96%
Other Long-Term Liabilities	$5.838M	$5.974M	$270.8M
YoY Change	-2.39%	-12.17%	-1.9%
Total Long-Term Liabilities	$1.052B	$1.046B	$1.036B
YoY Change	-2.5%	12.37%	12.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$692.7M	$689.3M	$689.3M
Total Long-Term Liabilities	$1.052B	$1.046B	$1.036B
Total Liabilities	$1.745B	$1.735B	$1.735B
YoY Change	2.44%	-5.83%	-5.83%
SHAREHOLDERS EQUITY
Retained Earnings	$3.760B	$3.614B
YoY Change	16.69%	17.34%
Common Stock	$1.702B	$1.682B
YoY Change	3.54%	3.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.433B	$3.361B	$3.361B
YoY Change
Total Liabilities & Shareholders Equity	$5.178B	$5.096B	$5.096B
YoY Change	9.48%	7.78%	7.78%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	$210.5M	$195.1M	$779.4M
YoY Change	3.37%	-0.02%	64.26%
Depreciation, Depletion And Amortization	$36.27M	$37.41M	$159.6M
YoY Change	-7.23%	1.78%	1.82%
Cash From Operating Activities	$44.66M	$79.49M	$351.1M
YoY Change	-168.02%	-64.91%	-52.34%
INVESTING ACTIVITIES
Capital Expenditures	$29.06M	-$32.39M	$134.8M
YoY Change	6.28%	5.09%	31.27%
Acquisitions	$19.10M		$42.78M
YoY Change			9.51%
Other Investing Activities	-$26.43M	-$22.85M	-$73.88M
YoY Change	162.21%	32.55%	77.45%
Cash From Investing Activities	-$58.81M	-$55.24M	-$229.9M
YoY Change	40.44%	14.94%	45.09%
FINANCING ACTIVITIES
Cash Dividend Paid	$64.43M		$245.3M
YoY Change	5.3%		8.22%
Common Stock Issuance & Retirement, Net			$47.38M
YoY Change			25.39%
Debt Paid & Issued, Net	$30.00M		$166.0M
YoY Change			-72.88%
Cash From Financing Activities	-$41.88M	57.50M	-$128.4M
YoY Change	-145.05%	-150.42%	-83.21%
NET CHANGE
Cash From Operating Activities	$44.66M	79.49M	$351.1M
Cash From Investing Activities	-$58.81M	-55.24M	-$229.9M
Cash From Financing Activities	-$41.88M	57.50M	-$128.4M
Net Change In Cash	-$66.55M	81.74M	-$21.57M
YoY Change	247.89%	26.88%	-87.15%
FREE CASH FLOW
Cash From Operating Activities	$44.66M	$79.49M	$351.1M
Capital Expenditures	$29.06M	-$32.39M	$134.8M
Free Cash Flow	$15.61M	$111.9M	$216.3M
YoY Change	-116.78%	-56.52%	-65.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	739372000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	670387000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	253575000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	225284000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201946000	usd
CY2022	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	31078000	usd
CY2021	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	31078000	usd
CY2020	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	30092000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	8673000	usd
CY2020	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000943819
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Entity File Number EntityFileNumber	001-15317
CY2022	dei	Entity Registrant Name EntityRegistrantName	ResMed Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0152841
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	9001 Spectrum Center Blvd.
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92123
CY2022	dei	Entity Address Country EntityAddressCountry	US
CY2022	dei	City Area Code CityAreaCode	858
CY2022	dei	Local Phone Number LocalPhoneNumber	836-5000
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.004 per share
CY2022	dei	Trading Symbol TradingSymbol	RMD
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021Q4	dei	Entity Public Float EntityPublicFloat	37771141000	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	146424981	shares
CY2022	dei	Auditor Name AuditorName	KPMG LLP
CY2022	dei	Auditor Location AuditorLocation	San Diego, CA
CY2022	dei	Auditor Firm AuditorFirmId	185
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	273710000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	295278000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23259000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	32138000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	575950000	usd
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	614292000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	743910000	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	457033000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	337908000	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	208154000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1931478000	usd
CY2022Q2	us-gaap	Assets Assets	5095853000	usd
CY2021Q2	us-gaap	Assets Assets	4728125000	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	1574757000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	498181000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	463490000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	132314000	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	128575000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1936442000	usd
CY2021Q2	us-gaap	Goodwill Goodwill	1927901000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	345944000	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	392582000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79746000	usd
CY2021Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79904000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	171748000	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	160916000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3164375000	usd
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3153368000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	159245000	usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	138008000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	344722000	usd
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	320599000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21856000	usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23585000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	108667000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	109611000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	44893000	usd
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	307963000	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9916000	usd
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	12000000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	689299000	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	911766000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	95455000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	91496000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	9714000	usd
CY2021Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	11319000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120453000	usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	114779000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5974000	usd
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6802000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	765325000	usd
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	643351000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	48882000	usd
CY2021Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	62933000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1045803000	usd
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	930680000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1735102000	usd
CY2021Q2	us-gaap	Liabilities Liabilities	1842446000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	188246955	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146410721	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	187484592	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	145648358	shares
CY2022Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	586000	usd
CY2021Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	583000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1682432000	usd
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1622199000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3613736000	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3079640000	usd
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	41836234	shares
CY2021Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	41836234	shares
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1623256000	usd
CY2021Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1623256000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-312747000	usd
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-193487000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3360751000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2885679000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5095853000	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4728125000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3578127000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3196825000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1514166000	usd
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1312598000	usd
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1189624000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39650000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45127000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49603000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1553816000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1357725000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1239227000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2024311000	usd
CY2021	us-gaap	Gross Profit GrossProfit	1839100000	usd
CY2020	us-gaap	Gross Profit GrossProfit	1717786000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	739372000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	670387000	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	676689000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	253575000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	225284000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201946000	usd
CY2022	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	31078000	usd
CY2021	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	31078000	usd
CY2020	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	30092000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	8673000	usd
CY2020	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-600000	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-600000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	935422000	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	908127000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1000286000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	903678000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	809659000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-22312000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-23627000	usd
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-39356000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8486000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25058000	usd
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-12202000	usd
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	14515000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1024025000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	935422000	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	908127000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1000286000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	903678000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	809659000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-22312000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-23627000	usd
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-39356000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25058000	usd
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-12202000	usd
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	14515000	usd
CY2020	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-14519000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3197000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	301000	usd
CY2020	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-14519000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3197000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	301000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2362000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-39803000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20016000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-76571000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	960483000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	883662000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	733088000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	181046000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2362000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-39803000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20016000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-76571000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	883662000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	733088000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	181046000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.27
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.30
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.24
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.27
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.30
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.24
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.27
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.68
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.56
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145313000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146451000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145652000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-119260000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	90495000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30973000	usd
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.27
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.68
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.56
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.56
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146066000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145313000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144338000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147043000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146451000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145652000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-119260000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	90495000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30973000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	660177000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	565000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	590701000	usd
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	2072193000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19987000	usd
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-46058000	usd
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	28197000	usd
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	57100000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30973000	usd
CY2020	us-gaap	Dividends Dividends	225093000	usd
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2497027000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3954000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-50207000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	33834000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	63927000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	90495000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	660177000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	565000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	590701000	usd
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	2072193000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19987000	usd
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-46058000	usd
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	28197000	usd
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	57100000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2020	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.56
CY2020	us-gaap	Dividends Dividends	225093000	usd
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2497027000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3954000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-50207000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	33834000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	63927000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	90495000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.56
CY2021	us-gaap	Dividends Dividends	226713000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2885679000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11205000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-52406000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	36180000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	65257000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-119260000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3360751000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	159609000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156758000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154850000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	34232000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154850000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.56
CY2021	us-gaap	Dividends Dividends	226713000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2885679000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-52406000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	36180000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	65257000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-119260000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.68
CY2022	us-gaap	Dividends Dividends	245341000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3360751000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	159609000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	34232000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156758000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	34760000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	65257000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	63927000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	57559000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8486000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25058000	usd
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	12202000	usd
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	-14515000	usd
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	14519000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	8673000	usd
CY2020	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	34760000	usd
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	26523000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	65257000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	63927000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	57559000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8486000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25058000	usd
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	12202000	usd
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	-14515000	usd
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	14519000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	8673000	usd
CY2020	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-19346000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	129195000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54383000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	311681000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21954000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58154000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58999000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-247632000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210708000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-23424000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	351147000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	736718000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	802255000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	134835000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102712000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-19346000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	129195000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54383000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	311681000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21954000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	69881000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	168109000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58154000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58999000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-247632000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210708000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-23424000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	351147000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	736718000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102712000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	95330000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	95330000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21201000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14114000	usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10608000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	42784000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	39067000	usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27910000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	20724000	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	21788000	usd
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	31616000	usd
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
CY2022	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	17176000	usd
CY2021	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-19219000	usd
CY2020	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	14397000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-229918000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21201000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14114000	usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10608000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	42784000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	39067000	usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27910000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	20724000	usd
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	31616000	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	6802000	usd
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
CY2022	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	17176000	usd
CY2021	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-19219000	usd
CY2020	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	14397000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-229918000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-158462000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-179861000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47384000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37790000	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	48182000	usd
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	46061000	usd
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	3500000	usd
CY2020	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	302000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	90000000	usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1190000000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	612000000	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1284012000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	245341000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	226713000	usd
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	225093000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-128363000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-179861000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47384000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37790000	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	48182000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	52406000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	50209000	usd
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	46061000	usd
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	3500000	usd
CY2020	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	302000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	288000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	90000000	usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1190000000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	166000000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	612000000	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1284012000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	245341000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	226713000	usd
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	225093000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-128363000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-764632000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-317286000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14434000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18498000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10920000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21568000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-167878000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	316028000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295278000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463156000	usd
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	147128000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	273710000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-764632000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-317286000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14434000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18498000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10920000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21568000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-167878000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	316028000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295278000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463156000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	273710000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295278000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	478120000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	221359000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	180359000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	22312000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	295278000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463156000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	478120000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	221359000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	180359000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	22312000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	23989000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	40377000	usd
CY2022	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	15648000	usd
CY2021	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	16671000	usd
CY2020	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	14919000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1543000	usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	4292000	usd
CY2022	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	38953000	usd
CY2021	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	24671000	usd
CY2020	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	20375000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	23989000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	40377000	usd
CY2020	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	14919000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	4672000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1543000	usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	4292000	usd
CY2022	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	38953000	usd
CY2021	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	24671000	usd
CY2020	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	20375000	usd
CY2022	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	4078000	usd
CY2021	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	0	usd
CY2020	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	0	usd
CY2022	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	-3067000	usd
CY2021	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	3768000	usd
CY2020	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	408000	usd
CY2022	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability		usd
CY2022	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	4078000	usd
CY2021	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	0	usd
CY2020	rmd	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination	0	usd
CY2022	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	-3067000	usd
CY2020	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	408000	usd
CY2022	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability		usd
CY2021	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	0	usd
CY2020	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	3500000	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	42784000	usd
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	43567000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	109611000	usd
CY2021	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	0	usd
CY2020	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	3500000	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	42784000	usd
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	43567000	usd
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	27910000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	108667000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	95455000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	108667000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	95455000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	91496000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	91496000	usd
CY2022	us-gaap	Depreciation Depreciation	81000000	usd
CY2021	us-gaap	Depreciation Depreciation	78400000	usd
CY2020	us-gaap	Depreciation Depreciation	65600000	usd
CY2022	us-gaap	Depreciation Depreciation	81000000	usd
CY2021	us-gaap	Depreciation Depreciation	78400000	usd
CY2020	us-gaap	Depreciation Depreciation	65600000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	602000000	usd
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	556400000	usd
CY2022Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	602000000	usd
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	556400000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	131265000	usd
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	128793000	usd
CY2021Q2	rmd	Prepaid Inventory PrepaidInventory	6952000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3077000	usd
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4647000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	385608000	usd
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	296967000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	743910000	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	457033000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	355225000	usd
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	155419000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3077000	usd
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4647000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	385608000	usd
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	296967000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	743910000	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	457033000	usd
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes	99352000	usd
CY2021Q2	us-gaap	Prepaid Taxes PrepaidTaxes	72409000	usd
CY2022Q2	rmd	Prepaid Inventory PrepaidInventory	107291000	usd
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes	99352000	usd
CY2021Q2	rmd	Prepaid Inventory PrepaidInventory	6952000	usd
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	128793000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	337908000	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	208154000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1131295000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1085629000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	633114000	usd
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	622139000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	498181000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	337908000	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	208154000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1131295000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1085629000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	633114000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	498181000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	463490000	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	463490000	usd
CY2021Q2	us-gaap	Goodwill Goodwill	1927901000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	38953000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-30412000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1936442000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	345944000	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	392582000	usd
CY2021Q2	us-gaap	Goodwill Goodwill	1927901000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	38953000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-30412000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1936442000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	345944000	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	392582000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	61374000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	57594000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	53157000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	47902000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	61374000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	57594000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	53157000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	47902000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	29667000	usd
CY2022Q2	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	9167000	usd
CY2021Q2	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	29084000	usd
CY2021Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	23002000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	9918000	usd
CY2021Q2	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	69240000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	29667000	usd
CY2022Q2	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	9167000	usd
CY2021Q2	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	29084000	usd
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	39290000	usd
CY2021Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	23002000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	9918000	usd
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	17154000	usd
CY2022Q2	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	58375000	usd
CY2021Q2	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	69240000	usd
CY2021Q2	rmd	Equity Investments EquityInvestments	69240000	usd
CY2022	rmd	Additional Equity Investments AdditionalEquityInvestments	9823000	usd
CY2022	rmd	Observable Price Adjustments On Non Marketable Equity Securities ObservablePriceAdjustmentsOnNonMarketableEquitySecurities	5367000	usd
CY2021Q2	rmd	Equity Investments EquityInvestments	69240000	usd
CY2022	rmd	Additional Equity Investments AdditionalEquityInvestments	9823000	usd
CY2022	rmd	Observable Price Adjustments On Non Marketable Equity Securities ObservablePriceAdjustmentsOnNonMarketableEquitySecurities	5367000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-18341000	usd
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	3981000	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	3209000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8486000	usd
CY2021	rmd	Additional Equity Investments AdditionalEquityInvestments	21788000	usd
CY2021	rmd	Observable Price Adjustments On Non Marketable Equity Securities ObservablePriceAdjustmentsOnNonMarketableEquitySecurities	1000000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	13515000	usd
CY2021	rmd	Reclassifications In Equity Investments ReclassificationsInEquityInvestments	0	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000	usd
CY2021Q2	rmd	Equity Investments EquityInvestments	69240000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-16200000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	14500000	usd
CY2020	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-14500000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-18341000	usd
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	3981000	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	3209000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8486000	usd
CY2022Q2	rmd	Equity Investments EquityInvestments	58375000	usd
CY2020Q2	rmd	Equity Investments EquityInvestments	44142000	usd
CY2021	rmd	Additional Equity Investments AdditionalEquityInvestments	21788000	usd
CY2021	rmd	Observable Price Adjustments On Non Marketable Equity Securities ObservablePriceAdjustmentsOnNonMarketableEquitySecurities	1000000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	13515000	usd
CY2021	rmd	Reclassifications In Equity Investments ReclassificationsInEquityInvestments	0	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000	usd
CY2021Q2	rmd	Equity Investments EquityInvestments	69240000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-16200000	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	14500000	usd
CY2020	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-14500000	usd
CY2021Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	4127000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	7983000	usd
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	8338000	usd
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	25889000	usd
CY2021Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	22032000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	25073000	usd
CY2021Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	21246000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	26340000	usd
CY2021Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	26542000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	194736000	usd
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	199917000	usd
CY2022Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	6485000	usd
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	25889000	usd
CY2021Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	22032000	usd
CY2021Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	21246000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	26340000	usd
CY2021Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	26542000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	194736000	usd
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	199917000	usd
CY2022Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	6485000	usd
CY2021Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	4127000	usd
CY2022Q2	rmd	Accrued Logistics And Occupancy Expenses Current AccruedLogisticsAndOccupancyExpensesCurrent	32160000	usd
CY2021Q2	rmd	Accrued Logistics And Occupancy Expenses Current AccruedLogisticsAndOccupancyExpensesCurrent	14954000	usd
CY2022Q2	rmd	Accrued Inventory In Transit AccruedInventoryInTransit	11554000	usd
CY2021Q2	rmd	Accrued Inventory In Transit AccruedInventoryInTransit	7146000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14502000	usd
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16297000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	344722000	usd
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	320599000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	22032000	usd
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	21132000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	17442000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	7983000	usd
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	8338000	usd
CY2022Q2	rmd	Accrued Logistics And Occupancy Expenses Current AccruedLogisticsAndOccupancyExpensesCurrent	32160000	usd
CY2021Q2	rmd	Accrued Logistics And Occupancy Expenses Current AccruedLogisticsAndOccupancyExpensesCurrent	14954000	usd
CY2022Q2	rmd	Accrued Inventory In Transit AccruedInventoryInTransit	11554000	usd
CY2021Q2	rmd	Accrued Inventory In Transit AccruedInventoryInTransit	7146000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14502000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	344722000	usd
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	320599000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	22032000	usd
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	21132000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	12124000	usd
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	14858000	usd
CY2022	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	1461000	usd
CY2021	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-1392000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25889000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	22032000	usd
CY2022Q2	rmd	Short Term Debt Gross ShortTermDebtGross	10000000	usd
CY2021Q2	rmd	Short Term Debt Gross ShortTermDebtGross	12000000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	84000	usd
CY2021Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	0	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9916000	usd
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	14366000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	12124000	usd
CY2021	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-1392000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25889000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	22032000	usd
CY2022Q2	rmd	Short Term Debt Gross ShortTermDebtGross	10000000	usd
CY2021Q2	rmd	Short Term Debt Gross ShortTermDebtGross	12000000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	84000	usd
CY2021Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	0	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9916000	usd
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	12000000	usd
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	646000000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4675000	usd
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	12000000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	770000000	usd
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	646000000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4675000	usd
CY2021Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2649000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	765325000	usd
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	643351000	usd
CY2022Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	775241000	usd
CY2021Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	655351000	usd
CY2022	rmd	Debt To Consolidated Ebitda Ratio DebtToConsolidatedEbitdaRatio	3.50
CY2022	rmd	Line Of Credit Facility Collateral Percentage Of The Company LineOfCreditFacilityCollateralPercentageOfTheCompany	0.100
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	35300000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	35500000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	25488000	usd
CY2022Q2	rmd	Lessee Operating Lease Lease Not Yet Commenced Commitments LesseeOperatingLeaseLeaseNotYetCommencedCommitments	700000	usd
CY2021Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2649000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	765325000	usd
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	643351000	usd
CY2021Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	655351000	usd
CY2022	rmd	Debt To Consolidated Ebitda Ratio DebtToConsolidatedEbitdaRatio	3.50
CY2022	rmd	Line Of Credit Facility Collateral Percentage Of The Company LineOfCreditFacilityCollateralPercentageOfTheCompany	0.100
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	35500000	usd
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	26500000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	161219000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	25488000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	19561000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	16617000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	68516000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	19561000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	16617000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	15783000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	15254000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	68516000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18910000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	142309000	usd
CY2022Q2	rmd	Lessee Operating Lease Lease Not Yet Commenced Commitments LesseeOperatingLeaseLeaseNotYetCommencedCommitments	700000	usd
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.028
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.030
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	41382000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	36130000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	93431000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y9M18D
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.028
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.030
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	26462000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	27734000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	41382000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	36130000	usd
CY2022	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	9342000	usd
CY2021	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	9758000	usd
CY2020	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	13457000	usd
CY2022	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	9342000	usd
CY2021	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	9758000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	90076000	usd
CY2020	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	13457000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	90076000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	93431000	usd
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	87874000	usd
CY2022	rmd	Lessor Lease Revenue LessorLeaseRevenue	99418000	usd
CY2021	rmd	Lessor Lease Revenue LessorLeaseRevenue	103189000	usd
CY2020	rmd	Lessor Lease Revenue LessorLeaseRevenue	101331000	usd
CY2021Q2	rmd	Sales Type Lease Lease Prepaid Taxes And Other Noncurrent Assets SalesTypeLeaseLeasePrepaidTaxesAndOtherNoncurrentAssets	6214000	usd
CY2022Q2	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	14108000	usd
CY2021Q2	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	14240000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	16068000	usd
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	87874000	usd
CY2022	rmd	Lessor Lease Revenue LessorLeaseRevenue	99418000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	6757000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	6757000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	4207000	usd
CY2021	rmd	Lessor Lease Revenue LessorLeaseRevenue	103189000	usd
CY2020	rmd	Lessor Lease Revenue LessorLeaseRevenue	101331000	usd
CY2022Q2	us-gaap	Sales Type Lease Lease Receivable SalesTypeLeaseLeaseReceivable	6473000	usd
CY2021Q2	us-gaap	Sales Type Lease Lease Receivable SalesTypeLeaseLeaseReceivable	8026000	usd
CY2022Q2	rmd	Sales Type Lease Lease Prepaid Taxes And Other Noncurrent Assets SalesTypeLeaseLeasePrepaidTaxesAndOtherNoncurrentAssets	7635000	usd
CY2021Q2	rmd	Sales Type Lease Lease Prepaid Taxes And Other Noncurrent Assets SalesTypeLeaseLeasePrepaidTaxesAndOtherNoncurrentAssets	6214000	usd
CY2022Q2	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	14108000	usd
CY2021Q2	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	14240000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	16068000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	4207000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	2057000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	1915000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter	0	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	1960000	usd
CY2014Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	20000000	shares
CY1997Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2022Q2	rmd	Reduction In Number Of Shares Of Common Stock Available For Issuance ReductionInNumberOfSharesOfCommonStockAvailableForIssuance	2.8
CY2022Q2	rmd	Maximum Number Of Shares Subject To Awards Granted MaximumNumberOfSharesSubjectToAwardsGranted	3000000	shares
CY2022Q2	rmd	Number Of Common Stock Granted NumberOfCommonStockGranted	4500000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	65500000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	59600000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	56800000	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	63.31
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	2057000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	1915000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears	1132000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter	0	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	1960000	usd
CY2022Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	14108000	usd
CY2014Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	20000000	shares
CY2014Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	20000000	shares
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	12900000	shares
CY1997Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY1997Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2022Q2	rmd	Reduction In Number Of Shares Of Common Stock Available For Issuance ReductionInNumberOfSharesOfCommonStockAvailableForIssuance	2.8
CY2022Q2	rmd	Maximum Number Of Shares Subject To Awards Granted MaximumNumberOfSharesSubjectToAwardsGranted	3000000	shares
CY2022Q2	rmd	Number Of Common Stock Granted NumberOfCommonStockGranted	4500000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	65500000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	59600000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	56800000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1060000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	97.01
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	256.33
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	177000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	110.19
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1060000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	97.01
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	256.33
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	177000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	63.31
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	110.19
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	938000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	112.91
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	96.14
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M18D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	932000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	112.10
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	33700000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8900000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	31200000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	93500000	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	89900000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	93400000	usd
CY2022	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	216000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	938000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	112.91
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M12D
CY2022Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	792000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	96.14
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M18D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	932000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	112.10
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	33700000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8900000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	31200000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	93500000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	93400000	usd
CY2022	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	216000	shares
CY2021	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	229000	shares
CY2020	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	265000	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65257000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	63927000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57559000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	29262000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	23346000	usd
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	39534000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	35995000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	40581000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	18025000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65257000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	63927000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57559000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	29262000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	23346000	usd
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	39534000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	35995000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	40581000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	18025000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	104000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	67000000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	141000000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164000000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146066000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145313000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144338000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	977000	shares
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	104000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	67000000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	141000000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164000000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	779437000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145313000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144338000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	977000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1138000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1138000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1314000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147043000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146451000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145652000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.34
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.30
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	71867000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	60548000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1046402000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	811795000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	672540000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	960483000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	883662000	usd
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1314000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147043000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146451000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145652000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.27
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.30
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.24
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.27
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-85919000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	71867000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	60548000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1046402000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	811795000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	672540000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	960483000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	883662000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	733088000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-115109000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9790000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	10700000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9041000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6898000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	177788000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	531812000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	124602000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	192864000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	425744000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	733088000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4376000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-115109000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9790000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	10700000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9041000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6898000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	177788000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	531812000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	124602000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	192864000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	425744000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	141290000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-12130000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-20935000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	141290000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12612000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-22791000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13000000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2773000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4205000	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3335000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3567000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	10409000	usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-13541000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11818000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16587000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12612000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13000000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2773000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4205000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3567000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	10409000	usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-13541000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11818000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16587000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29876000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	181046000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-4384000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-12130000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	201701000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	185569000	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	153949000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5703000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4836000	usd
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3563000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	17517000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	20257000	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	13595000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	858000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3785000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7216000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	201701000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	185569000	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	153949000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5703000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4836000	usd
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3563000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	20257000	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	13595000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	858000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3785000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7216000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-4384000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-20935000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	2299000	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	4026000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-11294000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4498000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-20696000	usd
CY2022	rmd	Effective Income Tax Rate Reconciliation Uncertain Tax Position Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionAmount	0	usd
CY2021	rmd	Effective Income Tax Rate Reconciliation Uncertain Tax Position Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionAmount	248773000	usd
CY2020	rmd	Effective Income Tax Rate Reconciliation Uncertain Tax Position Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionAmount	0	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	8278000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	17859000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	5938000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	181046000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	2299000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	7210000	usd
CY2021Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79904000	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	4026000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-11294000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4498000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-20696000	usd
CY2022	rmd	Effective Income Tax Rate Reconciliation Uncertain Tax Position Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionAmount	0	usd
CY2021	rmd	Effective Income Tax Rate Reconciliation Uncertain Tax Position Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionAmount	248773000	usd
CY2020	rmd	Effective Income Tax Rate Reconciliation Uncertain Tax Position Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionAmount	0	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	5938000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	181046000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79746000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	4814000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79746000	usd
CY2021Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79904000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	9714000	usd
CY2021Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	11319000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	70032000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	68585000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	28556000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	30080000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	7723000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	13753000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10570000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	11734000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	9714000	usd
CY2021Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	11319000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	70032000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	68585000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	28556000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	30080000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10570000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	11734000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	4814000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	4149000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	5096000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	7334000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27490000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33377000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	4715000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	4149000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	5096000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	7334000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27490000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33377000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	4715000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6912000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6425000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6080000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	25748000	usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	82074000	usd
CY2022Q2	rmd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	21702000	usd
CY2021Q2	rmd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	25751000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-3395000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-4911000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	221518000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6912000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6425000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6080000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	25748000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	17839000	usd
CY2022Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	82074000	usd
CY2021Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	58789000	usd
CY2022Q2	rmd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	21702000	usd
CY2021Q2	rmd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	25751000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-3395000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-4911000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	221518000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	210887000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13572000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13106000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	207946000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	210887000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13572000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13106000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	207946000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	197781000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	108078000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	104563000	usd
CY2022Q2	rmd	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	20345000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	9491000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	940000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	137914000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	129196000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	70032000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	68585000	usd
CY2022	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	38000000	usd
CY2022	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.26
CY2021	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	33600000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	197781000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	108078000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	104563000	usd
CY2022Q2	rmd	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	20345000	usd
CY2021Q2	rmd	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	23693000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	9491000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	940000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	137914000	usd
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	129196000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	70032000	usd
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	68585000	usd
CY2021	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	33600000	usd
CY2021	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.23
CY2020	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	43800000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3196825000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000	usd
CY2021	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.23
CY2020	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	43800000	usd
CY2020	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.30
CY2022Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	3600000000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3578127000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3196825000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	159609000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156758000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154850000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	159609000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156758000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154850000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3578127000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3196825000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000	usd
CY2021Q2	us-gaap	Noncurrent Assets NoncurrentAssets	498053000	usd
CY2020Q2	us-gaap	Noncurrent Assets NoncurrentAssets	463490000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	1251476000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	440067000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3578127000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000	usd
CY2022Q2	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	24200000	usd
CY2022	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	2100000	usd
CY2021Q2	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	30200000	usd
CY2021	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	8200000	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	1707951000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	13152000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	1431000	usd
CY2022Q2	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	8	patent
CY2022	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	157600000	usd
CY2021	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	153000000	usd
CY2022Q2	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	24200000	usd
CY2022	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	2100000	usd
CY2021	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	8200000	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	1707951000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	1251476000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	440067000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	usd
CY2022Q2	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	1825000	usd
CY2022Q2	us-gaap	Other Commitment OtherCommitment	994245000	usd
CY2022Q2	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	994245000	usd
CY2022Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	0	usd
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	2702196000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	2245721000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	440067000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	13152000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	1431000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	13152000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	1431000	usd
CY2022Q2	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	usd
CY2022Q2	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	1825000	usd
CY2022Q2	us-gaap	Other Commitment OtherCommitment	994245000	usd
CY2022Q2	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	994245000	usd
CY2022Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	0	usd
CY2022Q2	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	0	usd
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	2702196000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	2245721000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	440067000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	13152000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	1431000	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	0	usd
CY2022Q2	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	1825000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2020	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2022Q2	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	0	usd
CY2022Q2	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	1825000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2020	us-gaap	Restructuring Costs RestructuringCosts	0	usd

Files In Submission

Name	View Source	Status
0000943819-22-000010-index-headers.html	Edgar Link	pending
0000943819-22-000010-index.html	Edgar Link	pending
0000943819-22-000010.txt	Edgar Link	pending
0000943819-22-000010-xbrl.zip	Edgar Link	pending
ex1010-formofexecutiverest.htm	Edgar Link	pending
ex103-updatedformofexecuti.htm	Edgar Link	pending
ex106-formofrestrictedstoc.htm	Edgar Link	pending
ex107-formofstockoptiongra.htm	Edgar Link	pending
ex108-formofstockoptiongra.htm	Edgar Link	pending
ex109-formofpsuagreementfo.htm	Edgar Link	pending
ex311-ceocertification.htm	Edgar Link	pending
ex312-cfocertification.htm	Edgar Link	pending
ex321-ceoandcfocertificati.htm	Edgar Link	pending
exhibit211-subsidiaries.htm	Edgar Link	pending
exhibit231-auditorconsent.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmd-20220630.htm	Edgar Link	pending
rmd-20220630.xsd	Edgar Link	pending
rmd-20220630_g1.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
rmd-20220630_def.xml	Edgar Link	unprocessable
rmd-20220630_pre.xml	Edgar Link	unprocessable
rmd-20220630_lab.xml	Edgar Link	unprocessable
rmd-20220630_cal.xml	Edgar Link	unprocessable
rmd-20220630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMD
RESMED INC Stock $rmd

2022 Q3 Form 10-K Financial Statement

#000094381922000010 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD RESMED INC Stock $rmd

2022 Q3 Form 10-K Financial Statement

#000094381922000010 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD
RESMED INC Stock $rmd